<DOC>
	<DOCNO>NCT00745914</DOCNO>
	<brief_summary>To test hypothesis PPAR-gamma agonist , rosiglitazone , induces carotid plaque regression diabetic ESRD patient maintenance PD via anti-inflammatory property .</brief_summary>
	<brief_title>Peroxisome Proliferator-Activated Receptor-gamma ( PPAR-gamma ) Agonist Diabetic End-Stage Renal Disease Patients</brief_title>
	<detailed_description>End-stage renal disease ( ESRD ) patient increase risk accelerate atherosclerosis cardiovascular morbidity mortality . Non-traditional risk factor inflammation insulin resistance important contribution accelerate atherosclerosis ESRD patient receive long-term peritoneal dialysis ( PD ) . The peroxisome proliferator-activated receptor-g ( PPAR-g ) member nuclear receptor family ligand-dependent transcription factor . Activation PPAR-g show clinical experimental study anti-inflammatory anti-atherosclerotic property insulin-sensitizing effect . Recent study also show PPAR-g agonist reduce plaque inflammation inhibit activation proinflammatory gene responsible plaque development growth . Hence , study aim examine effect PPAR-g activation progression carotid plaque diabetic ESRD patient receive long-term PD use high-resolution magnetic resonance imaging ( MRI ) .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Diabetic ESRD patient receive longterm PD treatment , carotid plaque ( defined focal intimamedia thicken &gt; 1mm ) present screen ultrasonography Patients provide inform consent study Patients systemic inflammatory disease systemic lupus erythematosus Patients chronic liver disease cirrhosis Patients current active malignancy Patients chronic rheumatic heart disease congenital heart disease Patients poor general condition Patients plan live related kidney transplant within come 1 year Patients preexist class III/IV heart failure , Patients recurrent hypoglycemia Patients already glitazone treatment Female patient pregnancy Patients contraindication MRI examination include pacemaker metallic implant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>PPAR-gamma , diabetic , kidney disease , atherosclerosis</keyword>
</DOC>